263
Participants
Start Date
March 3, 2016
Primary Completion Date
June 28, 2019
Study Completion Date
June 28, 2019
Dapagliflozin
Dapagliflozin matching placebo
New York University, New York
St. Francis Hospital, Roslyn
University of Pennsylvania, Philadelphia
Walter Reed National Military Medical Center, Bethesda
University of Maryland, Baltimore
Duke University, Durham
Eastern Nephrology Associates, New Bern
Emory University, Atlanta
First Coast Cardiovascular Institute, Jacksonville
Charlotte Heart Group Research Center, Port Charlotte
Heart Group of the Eastern Shore, Fairhope
Vanderbilt University, Nashville
Cleveland Clinic, Cleveland
Henry Ford Health System, Detroit
Mayo Clinic, Rochester
Advocate Health and Hospitals, Oakbrook Terrace
NorthShore University HealthSystem Research Institute, Evanston
Northwestern University, Evanston
Washington University, St Louis
Truman Medical Center, Kansas City
Saint Luke's Hospital of Kansas City, Kansas City
Freeman Health System, Joplin
University of Texas Southwestern, Dallas
University of Southern Califiornia, Los Angeles
Brigham & Women's Hospital, Boston
Saint Luke's Health System
OTHER